Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Brickell Biotech, Inc. (BBI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.2145-0.0141 (-6.17%)
At close: 04:00PM EST
0.2140 -0.00 (-0.23%)
After hours: 07:38PM EST
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
Total Revenue
327
1,822
7,917
1,622
Cost of Revenue
-
-
-
1,436
Gross Profit
-
-
-
186
Operating Expense
41,667
22,798
32,385
21,268
Operating Income
-41,340
-20,976
-24,468
-19,646
Net Non Operating Interest Income Expense
-65
0
-2,096
-1,029
Other Income Expense
633
63
2,687
3,392
Pretax Income
-40,772
-20,913
-23,877
-16,254
Net Income Common Stockholders
-40,772
-20,913
-13,603
-16,254
Diluted NI Available to Com Stockholders
-40,772
-20,913
-13,603
-16,254
Basic EPS
-
-0.85
-4.50
-5.18
Diluted EPS
-
-0.85
-4.50
-5.18
Basic Average Shares
-
24,514
3,023
3,120
Diluted Average Shares
-
24,514
3,023
3,120
Total Operating Income as Reported
-41,340
-20,976
-24,468
-19,646
Total Expenses
41,667
22,798
32,385
21,268
Net Income from Continuing & Discontinued Operation
-40,772
-20,913
-23,877
-16,254
Normalized Income
-41,405
-20,976
-26,564
-19,646
Interest Income
-
-
-
61
Interest Expense
65
0
2,096
1,090
Net Interest Income
-65
0
-2,096
-1,029
EBIT
-40,707
-20,913
-21,781
-19,646
EBITDA
-40,691
-
-
-
Reconciled Cost of Revenue
-
-
-
1,436
Reconciled Depreciation
16
10
28
151
Net Income from Continuing Operation Net Minority Interest
-40,772
-20,913
-23,877
-16,254
Total Unusual Items Excluding Goodwill
633
63
2,687
3,392
Total Unusual Items
633
63
2,687
3,392
Normalized EBITDA
-41,324
-20,966
-24,440
-22,887
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
Advertisement
Advertisement